Tekla Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Tekla Capital Management’s Portfolio MLTX Stock Details MLTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell
2022 Q4	$3.15M	Hold
2022 Q3	$2.39M	Buy
2022 Q2	–	Sell
2022 Q1	$2.77M	Hold
2021 Q4	$2.47M	Hold
2021 Q3	$2.47M	Hold
2021 Q2	$2.58M	Hold
2021 Q1	$2.56M	Hold
2020 Q4	$2.71M	Buy